explore -WSS

explore

author：hotspot 2025-09-27 23:00:58 - browse：9

Adam's take main illustration — Molly Ferguson/STAT

The approval Friday of Bluebird Bio’s gene therapy for sickle cell disease should have been a momentum-swinging achievement for the long-struggling biotech. Instead, the company mispriced its new drug and fumbled a pivotal financial lifeline.

The consequences of these strategic blunders — arguably, self-inflicted — could imperil Bluebird’s independence, perhaps even its survival.

Bluebird priced Lyfgenia at $3.1 million, while Vertex Pharmaceutical set the cost of Casgevy, its competing sickle cell treatment also approved on Friday, at $2.2 million. Not only is Lyfgenia significantly more expensive, but its prescribing label carries a “black box” safety warning, which requires patients undergo regular blood monitoring for cancer risk. Casgevy has no similar monitoring requirement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Parents surprise family after baby discharged from NICU after 170 days

WSS

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Teachers share how revamped forgiveness program helped with their student loans

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Swim instructor mom warns parents not to buy blue swimsuits for kids

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

leisure time

explore

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

What to know about Saharan dust affecting the US and how it can affect health

Medicare details structure of new drug price negotiation program

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

The high cost of giving birth even with insurance

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Teachers share how revamped forgiveness program helped with their student loans

Medical records are filled with copy

In new study, freeze

hotspot

The U.S. needs a new definition of substance use “recovery”

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Eisai exec who led development of Alzheimer’s drug to retire

Providers still hesitate to prescribe buprenorphine, study finds

Judge agrees to delay next hearing in Trump classified documents case

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

focus

hotspot

leisure time

knowledge